Wake Forest Baptist Health | Strategic Alliance Partners

Latest from Wake Forest Baptist Health


Marking 25 Years of Progress in Blood and Marrow Transplantation

December 25, 2015

While major accomplishments in blood and marrow transplantation (BMT) were being made around the country, the first BMT program at Wake Forest Baptist came into view, a vision brought to life by David D. Hurd, MD.

BRCA Testing and Contralateral Prophylactic Mastectomy

January 13, 2015

Determination of BRCA1 and 2 mutation carrier status has become increasingly important. Estimates suggest that about 80% of breast cancers and 90% of ovarian cancers are sporadic; while only 5% to 10% of breast cancers are hereditary.

Advancing Prostate Cancer Care

October 12, 2014

The prostate cancer team at the Comprehensive Cancer Center at Wake Forest Baptist Medical Center has recently focused on two primary areas: minimally invasive care and clinical research.

Transoral Surgery for Oropharyngeal Squamous Cell Carcinoma

August 11, 2014

The incidence of oropharyngeal squamous cell carcinoma (OPSCC) has been steadily increasing over the last few decades, mostly due to HPV, which is now associated with the majority of newly diagnosed cases of OPSCC.

Hot Flash Treatments That Help Women Fail to Benefit Androgen-Deprived Men

December 20, 2013

Men who experience hot flashes because they are undergoing androgen-deprivation therapy for prostate cancer are not significantly helped by two treatments that alleviate that symptom in menopausal women, the results of a study show.

Wake Forest Baptist More Than Doubles Cancer Center Size, Adds More Providers

December 09, 2013

To respond to the growing demand in cancer services that the existing cancer center was experiencing, Wake Forest Baptist Medical Center is expanding its comprehensive cancer center to help patients cope with the daunting challenges of cancer diagnosis and treatment.

Multidisciplinary Melanoma Program Facilitates Patient Care and Clinical Research

November 19, 2013

The Malignant Melanoma Program at Wake Forest Baptist Health employs a multidisciplinary approach for the management of patients with all stages of this disease. The goals of the program are centered on unequivocal excellence in all areas of care for patients with malignant melanoma.

Predicting Treatment Outcomes in Older Adults With AML

July 31, 2013

Measurable patient characteristics that predict better tolerance have not been widely studied and are desperately needed in clinical practice to inform treatment decision-making and individualize care for each older adult with AML.

Dr. Powell Discusses the Next Steps for CPI-613

July 25, 2013

Bayard L. Powell, MD, the Director-At-Large and a Professor in Hematology & Oncology at the Wake Forest Baptist Medical Center Comprehensive Cancer Center, discusses the next steps for CPI-613 in hematologic malignancies.

Genetic Alterations Linked to Poorer Prostate Cancer Prognosis

July 16, 2013

Alterations in the chromosomes of two genes have been implicated in an increased risk of prostate cancer mortality, and the discovery holds promise for distinguishing which patients are candidates for more aggressive therapy.